Publications by authors named "Ishaq F Abdul"
Article Synopsis
- Gestational Diabetes Mellitus (GDM) is increasingly recognized as a significant issue leading to complications for mothers and babies during pregnancy.
- A study involving 215 pregnant women found that 9% had GDM, with abnormal fasting plasma glucose and higher birth weights compared to those without diabetes.
- GDM is associated with fewer vaginal deliveries and a 50% rate of neonatal admissions, highlighting its impact on maternal and neonatal health.
Article Synopsis
- A study conducted at the University of Ilorin Teaching Hospital revealed that many blood units crossed-matched for Caesarean sections in Nigeria go unused, contributing to high blood wastage and costs.* -
- The efficiency of blood usage was assessed using metrics like the cross-match to transfusion (C/T) ratio, which indicated poor utilization with a C/T ratio of 3.1 and over 68% of blood wasted.* -
- The study recommends implementing a Maximal Surgical Blood Order Schedule (MSBOS) to better estimate blood needs for Caesarean sections, along with tailored blood grouping practices based on patient risk levels.*
Background: Uterine fibroids are the commonest tumour of the female genital tract; about one third are symptomatic and require management. The treatment of uterine fibroids may be medical, surgical, conservative or expectant. Myomectomy is the common surgical treatment option for women failing medical management and desiring to preserve fertility and/or their uterus.
View Article and Find Full Text PDFObjective: To compare the efficacy of oral misoprostol with that of oxytocin for active management of the third stage of labor (AMTSL).
Methods: A double-blind randomized control trial was undertaken at a center in Ilorin, Nigeria, between January and June 2013. Every other eligible patient (in the first stage of labor at term, to have a spontaneous vaginal delivery, and no/low risk of postpartum hemorrhage [PPH]) were randomly assigned with computer-generated random numbers to receive oral misoprostol (600μg) plus placebo injection or oral placebo plus oxytocin injection (1mL of 10IU) in the third stage of labor.